May 31, 2016 Clinical Research/Diagn. M&A, Partnerships

GE Healthcare joins high-profile vaccine collaboration to explore vaccine self-sufficiency and pandemic preparedness in Saudi Arabia as part of 2030 Vision

CHALFONT ST. GILES, UK AND RIYADH, SAUDI ARABIA – 31 May 2016 – GE Healthcare is entering into a vaccine collaboration with the National Industrial Clusters Development Program (NICDP) under the Ministry of Energy, Industry and Mineral Resources, SaudiVax and King Saud University, to enable vaccine self-sufficiency and pandemic preparedness in the Kingdom of Saudi... Read more

May 31, 2016 Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

Beckman Coulter and Ortho Clinical Diagnostics Announce Strategic Relationship to Deliver Infectious Disease Testing Menu to Very High-Volume Labs Beckman Coulter Sample Press Release

Beckman Coulter Diagnostics to Place Ortho’s VITROS® 3600 Systems in Very High-Volume Labs; Expands Reach for Ortho and Broadens Menu for Beckman Coulter    BREA, CA, and RARITAN, NJ, June 8, 2016 — Beckman Coulter, Inc., a global developer and manufacturer of clinical diagnostic products, and Ortho Clinical Diagnostics (Ortho), a global in vitro diagnostics... Read more

May 19, 2016 Bio/Pharma/CRO Clinical Research/Diagn. PR/Corporate

Takara Bio presents HF10 Phase II clinical trial data at American Society of Clinical Oncology

2016 2016/05/19 Takara Bio presents HF10 Phase II clinical trial data at American Society of Clinical Oncology Kusatsu/Shiga, Japan — May 19, 2016 – Takara Bio Inc. announces that HF10 US Phase II clinical trial data will be presented at  the 2016 Annual Meeting of the American Society of Clinical Oncology (May29 – June 2, 2016,... Read more

May 6, 2016 Clinical Research/Diagn. Lab Top-10 PR/Corporate

Beckman Coulter Features Prostate Health Index (phi) at 2016 AUA Annual Meeting

PROSTATE HEALTH INDEX (phi) BLOOD TEST GIVES YOU MORE CONFIDENCE BEFORE BIOPSY, REDUCING UNNECESSARY BIOPSIES BY 30%   BREA, CALIF. — (May 6, 2016) — Beckman Coulter Diagnostics, a leader in prostate cancer testing, will demonstrate its dedication to advancing healthcare for patients and physicians at the 2016 American Urological Association (AUA) Annual Meeting in... Read more

May 5, 2016 Clinical Research/Diagn.

Barnes-Jewish Hospital Installs the Industry’s First General Purpose Digital SPECT/CT

St. Louis, MO – May 5, 2016 – Doctors and researchers at Barnes-Jewish Hospital and Washington University in St. Louis may be able to better diagnose and monitor diseases at a functional level with GE Healthcare’s next-generation SPECT/CT system, Discovery NM/CT 670 CZT. The new SPECT/CT is the world’s first general purpose, ultra-high resolution SPECT/CT... Read more

April 4, 2016 Clinical Research/Diagn.

Greiner Bio-One: Strategic Change in the Diagnostics Field

Kremsmünster/Rainbach/Frickenhausen, April 4, 2016 – Greiner Bio-One, a leading international medical technology company and part of Greiner Holding AG, will in future limit its activities in the diagnostics field to the production and distribution of existing products. Greiner Bio-One Diagnostics GmbH, which is based in Rainbach im Mühlkreis, develops molecular analysis methods that enable bacteria... Read more

March 7, 2016 Bio/Pharma/CRO Clinical Research/Diagn. Product Launch

Path Links, a pathology network in Northern Lincolnshire, upgrades to digital pathology to enhance cancer diagnostics capability

Lincoln, UK, 08 March 2016 – Path Links, the single managed NHS clinical pathology service operating across Lincolnshire, has upgraded to digital pathology to continue its focus on providing the highest quality diagnostic services for Northern Lincolnshire & Goole NHS Foundation Trust, United Lincolnshire Hospitals NHS Trust and 186 General Practices across the county. Path... Read more

January 21, 2016 Clinical Research/Diagn. Lab Top-10

New Access TSH (3rd IS) Assay Released with CE Mark for Use on the Beckman Coulter Access Family of Immunoassay Systems

  NYON, SWITZERLAND – (January 21, 2016) – Beckman Coulter Diagnostics is pleased to announce obtaining CE Mark and the release of its new Access TSH (3rd IS) assay for use with the company’s Access Family of Immunoassay Systems. This new assay is the next generation of the Access HYPERsensitive hTSH and Access Fast hTSH... Read more

January 13, 2016 Clinical Research/Diagn.

GE Healthcare, FedDev Ontario commit CAD $40M for new CCRM-led centre to solve cell therapy manufacturing challenges

Chalfont St. Giles, UK and Toronto, Canada – 13 January 2016 – GE Healthcare, the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), and the Centre for Commercialization of Regenerative Medicine (CCRM) are building a centre for advanced therapeutic cell technologies in Toronto with an investment of CAD $40M from GE and FedDev Ontario.... Read more

December 14, 2015 Cell Analysis Tools Clinical Research/Diagn. Lab Top-10

Leading Cancer Research Lab Announced as Winner in Beckman Coulter’s $…

Beckman Coulter Inc – Beckman Coulter, Inc. JavaScript is required for this site. Please enable JavasScript for your browser. Change Password * Indicates required fields Change Email Address * Indicates required fields Confirm Country Selection Forgot Password * Indicates required fields   Forgot your password? Please provide the email address and your last name associated... Read more